Ronald Blue Trust, Inc. Omeros Corp Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 3,090 shares of OMER stock, worth $26,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,090
Previous 5,000
38.2%
Holding current value
$26,017
Previous $49,000
38.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OMER
# of Institutions
142Shares Held
26.9MCall Options Held
959KPut Options Held
732K-
Black Rock Inc. New York, NY4.1MShares$34.5 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$33.7 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$26.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.84MShares$15.5 Million0.01% of portfolio
-
Stifel Financial Corp St. Louis, MO1.58MShares$13.3 Million0.02% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $528M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...